Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

PLAC4 Inhibitors

PLAC4 inhibitors constitute a chemical class designed to regulate the activity of PLAC4, a protein with a predominant expression in the placenta. These inhibitors do not directly target PLAC4; instead, their mechanism of action is centered on modifying the cellular and genetic contexts that govern PLAC4 expression and function. A significant portion of this class includes compounds that affect epigenetic mechanisms. These inhibitors operate by altering the chromatin state, thereby influencing gene expression patterns at a fundamental level. By modifying epigenetic marks like DNA methylation and histone acetylation, they can effectively regulate the transcriptional activity of genes associated with PLAC4. The modulation of DNA methylation involves the inhibition of DNA methyltransferases, enzymes that add methyl groups to the DNA molecule, typically leading to the repression of gene expression. On the other hand, the inhibition of histone deacetylases results in the retention of acetyl groups on histones, promoting a more relaxed chromatin structure that can facilitate gene expression. Through these epigenetic alterations, PLAC4 inhibitors can regulate the expression of PLAC4 in cells, offering an indirect route to influence its activity.

In addition to epigenetic modification, some members of the PLAC4 inhibitor class focus on other cellular pathways and mechanisms that indirectly affect the function of PLAC4. These compounds interact with various cellular processes, such as signal transduction, transcription regulation, and other molecular pathways that are upstream or related to PLAC4's role in the cell. By targeting these broader cellular mechanisms, PLAC4 inhibitors can create a cascade of molecular events that ultimately influence the activity and expression of PLAC4. This approach underscores the interconnected nature of cellular processes and how modulation in one area can have far-reaching effects on other components, including specific proteins like PLAC4. The development and application of PLAC4 inhibitors highlight the sophistication of contemporary strategies in protein regulation. Instead of direct interaction with the target protein, these inhibitors demonstrate the efficacy of manipulating the wider cellular environment and molecular pathways to achieve desired changes in protein activity. This method reflects an advanced understanding of the complex biological networks within cells and represents a refined approach to modulating protein function.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor, it can affect gene expression and could possibly inhibit PLAC4 by altering epigenetic regulation.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

As a histone deacetylase inhibitor, it influences chromatin remodeling and gene expression, potentially affecting PLAC4.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Another histone deacetylase inhibitor, Vorinostat could possibly inhibit PLAC4 through epigenetic modulation.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

Similar to 5-Azacytidine, this DNA methyltransferase inhibitor could possibly inhibit PLAC4 by affecting gene expression patterns.

Valproic Acid

99-66-1sc-213144
10 g
$85.00
9
(1)

Used as a histone deacetylase inhibitor, it could possibly inhibit PLAC4 through epigenetic mechanisms.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$88.00
$208.00
24
(2)

A selective histone deacetylase inhibitor, Entinostat could possibly inhibit PLAC4 by altering gene expression.

Romidepsin

128517-07-7sc-364603
sc-364603A
1 mg
5 mg
$214.00
$622.00
1
(1)

This histone deacetylase inhibitor could possibly inhibit PLAC4 by impacting chromatin structure and gene expression.

Panobinostat

404950-80-7sc-208148
10 mg
$196.00
9
(1)

As a broad-spectrum histone deacetylase inhibitor, Panobinostat could possibly inhibit PLAC4 by modulating gene expression.

Belinostat

414864-00-9sc-269851
sc-269851A
10 mg
100 mg
$153.00
$561.00
(1)

Another histone deacetylase inhibitor, Belinostat could possibly inhibit PLAC4 through changes in gene expression.

CI 994

112522-64-2sc-205245
sc-205245A
10 mg
50 mg
$97.00
$525.00
1
(2)

A histone deacetylase inhibitor, Tacedinaline could possibly inhibit PLAC4 by affecting chromatin and gene expression.